Neuland seals deal with LIR Life Sciences for transdermal GLP-1
CDMO to advance biotech’s novel cell-penetrating peptides for next-generation obesity therapies
CDMO to advance biotech’s novel cell-penetrating peptides for next-generation obesity therapies
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
Subscribe To Our Newsletter & Stay Updated